Ikxinta – at the forefront of thriving biotech innovation
As scientists, the founders Dr. Pablo Lizana Allende and Dr. Michael Rossbach, bring a science mindset to strategy consulting. Life sciences has emerged as one of the most dynamic sectors in the global economy, and Spain, with its rich history of research, has become a significant player in the field. The expansion of Spain’s biotech sector can be attributed to government funding, innovation initiatives, and a commitment to academic excellence. Institutions like the Spanish National Research Council, the Institute for Health Carlos III in Madrid, or The University of the Basque Country have made significant contributions to the sector. Ikxinta connects such institutions with partners in academia, clinics, or in the bio/pharmaceutical industry to drive innovation from research into clinical practice.
Today, many scientific projects focus on genomics, cell-based therapeutics, drug discovery, bio-IT, or medical devices – they benefit from supportive ecosystems that include accelerators, and venture capital. Notable success stories are Grifols in Barcelona (a global leader in plasma-derived therapies), or Progenika Biopharma in the Basque Country (innovative diagnostics for rare or complex genetic diseases).
In the dynamic landscape of the global biotech sector, Spain is well-positioned to sustain its leadership, driving advancements that transcend national boundaries. This underscores the potential for scientific innovation in regions dedicated to R&D, benefiting both their own nations and the broader global healthcare community.
Our Ikxinta team, spanning across Portugal, Spain, France, the Netherlands, Germany, the United Kingdom, China and Singapore, comprises consultants, entrepreneurs, investors, and scientists. We actively nurture unique collaborations, introduce emerging technologies to the market, and create new ventures – with a hands-on approach.
Prof. Dr. Michael Rossbach,